DOCS vs PRVA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 16, 2026
DOCS
PRVA
Investment Advisor Scores
PRVA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | DOCS | PRVA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 15.2207 | 30.2115 | DOCS |
| PEG Ratio | 0.5895 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 5.1% | 25.8% | PRVA |
| Earnings Growth | -69.0% | -33.3% | PRVA |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 57.6/100 | 53.9/100 | DOCS |
| Profit Margin | 30.4% | 1.0% | DOCS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
DOCS
DistributionPrice near a flattening SMA50 (slope -3.9%) with fading momentum, RSI 47
PRVA
NeutralMixed signals - no dominant trend phase, RSI 35
Fundamentals Snapshot
| Metric | DOCS | PRVA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 12.9 | 21.6 |
| Trailing P/E | 22.1 | 140.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.3% |
| Gross Margin | 0.9% | 0.1% |
| Operating Margin | 0.2% | 0.0% |
| EPS | 0.96 | 0.17 |
| Dividend Yield | — | — |